DWA
RMD icon

Dorsey Wright & Associates’s ResMed RMD Stock Holding History

Dorsey Wright & Associates’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,222
Closed -$2.27M – 376
2020
Q3 		$2.27M Sell
13,222
-418
-3% -$77.2K 0.41% 75
2020
Q2 		$2.62M Sell
13,640
-993
-7% -$162K 0.53% 62
2020
Q1 		$2.15M Buy
+14,633
New +$2.33M 0.82% 56
2019
Q1 		– Sell
-2,536
Closed -$289K – 320
2018
Q4 		$289K Sell
2,536
-145
-5% -$15.5K 0.09% 103
2018
Q3 		$309K Buy
+2,681
New +$294K 0.06% 111
2013
Q3 		– Sell
-17,400
Closed -$785K – 128
2013
Q2 		$785K Buy
+17,400
New +$826K 0.13% 64

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dorsey Wright & Associates's RMD Position: Q4 2020 in Review

Dorsey Wright & Associates sold out of ResMed (RMD) in Q4 2020, closing a stake of 13,222 shares — an estimated $2.27M sold.

Dorsey Wright & Associates first reported a position in RMD in Q2 2013 and held it in 6 quarters. The position peaked at $2.62M in Q2 2020. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

  • Dorsey Wright & Associates reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 13,222 ResMed shares in Q4 2020, an estimated $2.27M.
  • Dorsey Wright & Associates first reported a position in ResMed in Q2 2013 and held it in 6 quarters.
  • Dorsey Wright & Associates's ResMed position peaked at $2.62M in Q2 2020.
  • 663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Dorsey Wright & Associates's 13F filing for Q4 2020, filed 28 Jan 2021.